Down's syndrome is associated with increased 8,12-iso-iPF(2α)-VI levels: Evidence for enhanced lipid peroxidation in vivo

Annals of Neurology

Volumn 48, Issue 5, 2000, Pages 795-798

  Praticò, Domenico ^a   Iuliano, Luigi ^b   Amerio, Giulia ^c   Tang, Lina X ^a   Rokach, Joshua ^d   Sabatino, Giuseppe ^c   Violi, Francesco ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d Florida Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; 8,12 ISOPROSTAGLANDIN F2 ALPHA; LIPID; PROSTAGLANDIN F2 ALPHA; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADOLESCENT; ALZHEIMER DISEASE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DOWN SYNDROME; FEMALE; GENE OVEREXPRESSION; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; TRISOMY 21; URINALYSIS;

EID: 0033761958     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200011)48:5<795::AID-ANA15>3.3.CO;2-R     Document Type: Article

References (20)

1. The neurobiologic consequences of Down syndrome
2. Down syndrome clinical symptoms are manifested in transfected and transgenic mice over-expressing the human Cu/Zn-superoxide dismutase gene
3. Reactive oxygen species and their contribution to pathology in Down syndrome
4. Early glycoxidation damage in brains from Down's syndrome
5. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice over-expressing Cu/Zn-superoxide dismutase: Implication for Down's syndrome
6. 2-isoprostanes: Sensitive and specific non-invasive indices of lipid peroxidation in vivo
7. 2-isoprostanes in human urine
8. The causes of Down syndrome
9. Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease
10. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
11. Oxidative stress and neural dysfunction in Down syndrome
12. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome
13. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
14. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
15. An intracellular protein that binds amyloid beta peptide and mediates neurotoxicity in Alzheimer's disease
16. 2-isoprostanes in Alzheimer's disease: Evidence of enhanced lipid peroxidation in vivo
17. 2-isoprostane levels are increased in Alzheimer's disease
18. Evidence against increased oxidative DNA-damage in Down syndrome
19. Biomarkers of oxidative stress are significantly elevated in Down syndrome